Inogen | INGN - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Abbott USD 52.13B 1.3B 2025-12
Accuray USD 61.87M 19.3M 2025-09
AngioDynamics USD 185.87M 898K 2025-02
Artivion USD 438.69M 18.79M 2025-09
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Chart Industries USD 3.23B 28.2M 2025-12
Cooper Companies USD 8.24B 113.7M 2025-09
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Globus Medical USD 4.57B 174.42M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.86B 964M 2025-09
Orthofix International USD 442.49M 15.86M 2025-09
Philips EUR 10.58B 204M 2025-09
ResMed USD 6.32B 199.61M 2025-12
Steris USD 7.15B 145.4M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
X T L Biopharmaceuticals USD -47K 5.48M 2025-06
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12